AR057643A1 - Lacosamida para terapia adjunta - Google Patents
Lacosamida para terapia adjuntaInfo
- Publication number
- AR057643A1 AR057643A1 ARP060100304A ARP060100304A AR057643A1 AR 057643 A1 AR057643 A1 AR 057643A1 AR P060100304 A ARP060100304 A AR P060100304A AR P060100304 A ARP060100304 A AR P060100304A AR 057643 A1 AR057643 A1 AR 057643A1
- Authority
- AR
- Argentina
- Prior art keywords
- lacosamide
- therapy
- attached
- attached therapy
- antipsychotics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Uso de una clase de compuestos péptidos para la prevencion, alivio y/o tratamiento de una enfermedad tratada con antipsicoticos, en particular psicosis, más particularmente, esquizofrenia, en una terapia adjunta a al menos un antipsicotico.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US64741005P | 2005-01-28 | 2005-01-28 | |
EP05001843A EP1688137A1 (en) | 2005-01-28 | 2005-01-28 | SPM 927 for add-on therapy of schizophrenia |
Publications (1)
Publication Number | Publication Date |
---|---|
AR057643A1 true AR057643A1 (es) | 2007-12-12 |
Family
ID=36636204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060100304A AR057643A1 (es) | 2005-01-28 | 2006-01-27 | Lacosamida para terapia adjunta |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP1841417A2 (es) |
JP (1) | JP2008528532A (es) |
KR (1) | KR20070096058A (es) |
AR (1) | AR057643A1 (es) |
AU (1) | AU2006208630B2 (es) |
BR (1) | BRPI0607043A2 (es) |
CA (1) | CA2595330A1 (es) |
EA (1) | EA015566B1 (es) |
IL (1) | IL183973A0 (es) |
MX (1) | MX2007009070A (es) |
NO (1) | NO20074361L (es) |
WO (1) | WO2006079547A2 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101466390B (zh) | 2006-06-15 | 2014-03-12 | 优时比制药有限公司 | 用于治疗难治性癫痫持续状态的肽类化合物 |
EP2992891B1 (en) | 2006-06-15 | 2020-08-05 | UCB Pharma GmbH | Pharmaceutical composition comprising brivaracetam and lacosamide with synergistic anticonvulsant effect |
EP1920780A1 (en) * | 2006-10-12 | 2008-05-14 | Schwarz Pharma Ag | Peptide compounds for the treatment of hyperexcitability disorders |
EP1873527A1 (en) | 2006-06-30 | 2008-01-02 | Schwarz Pharma Ag | Method for identifying CRMP modulators |
WO2009053070A1 (en) | 2007-10-23 | 2009-04-30 | Schwarz Pharma Ag | Compounds for treating demyelination conditions |
WO2010077916A1 (en) * | 2008-12-16 | 2010-07-08 | Eurand, Inc. | Compositions comprising melperone |
JP6027539B2 (ja) | 2010-12-02 | 2016-11-16 | ウーツェーベー ファルマ ゲーエムベーハーUcb Pharma Gmbh | ラコサミドの1日1回投与用製剤 |
EP2468261A1 (en) | 2010-12-02 | 2012-06-27 | UCB Pharma GmbH | Formulation of lacosamide |
CN115813887A (zh) | 2016-12-20 | 2023-03-21 | 罗曼治疗系统股份公司 | 包含阿塞那平的透皮治疗系统 |
US11337932B2 (en) | 2016-12-20 | 2022-05-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene |
CA3067938A1 (en) | 2017-06-26 | 2019-01-03 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer |
EP3720435B1 (en) | 2017-12-05 | 2024-03-06 | Sunovion Pharmaceuticals Inc. | Crystal forms and production methods thereof |
BR112020011189A2 (pt) | 2017-12-05 | 2020-11-17 | Sunovion Pharmaceuticals Inc. | misturas não racêmicas e usos das mesmas |
KR20210022656A (ko) | 2018-06-20 | 2021-03-03 | 에르테에스 로만 테라피-시스테메 아게 | 아세나핀을 함유하는 경피 치료 시스템 |
JP2022535893A (ja) | 2019-06-04 | 2022-08-10 | サノビオン ファーマシューティカルズ インク | 放出調節製剤およびその使用 |
US11278634B1 (en) | 2021-02-12 | 2022-03-22 | Extrovis Ag | Stable parenteral composition of lacosamide |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5378729A (en) * | 1985-02-15 | 1995-01-03 | Research Corporation Technologies, Inc. | Amino acid derivative anticonvulsant |
US5773475A (en) | 1997-03-17 | 1998-06-30 | Research Corporation Technologies, Inc. | Anticonvulsant enantiomeric amino acid derivatives |
ATE327744T1 (de) | 2001-03-20 | 2006-06-15 | Sanol Arznei Schwarz Gmbh | Neue verwendung von peptidverbindungen bei der behandlung von nicht-neuropathischem entzündungsschmerz |
EP1243263B1 (en) | 2001-03-21 | 2002-11-27 | Schwarz Pharma Ag | Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
-
2006
- 2006-01-27 KR KR1020077019581A patent/KR20070096058A/ko not_active Application Discontinuation
- 2006-01-27 WO PCT/EP2006/000722 patent/WO2006079547A2/en active Application Filing
- 2006-01-27 MX MX2007009070A patent/MX2007009070A/es active IP Right Grant
- 2006-01-27 AR ARP060100304A patent/AR057643A1/es not_active Application Discontinuation
- 2006-01-27 BR BRPI0607043-4A patent/BRPI0607043A2/pt not_active IP Right Cessation
- 2006-01-27 AU AU2006208630A patent/AU2006208630B2/en not_active Ceased
- 2006-01-27 CA CA002595330A patent/CA2595330A1/en not_active Abandoned
- 2006-01-27 EA EA200701594A patent/EA015566B1/ru not_active IP Right Cessation
- 2006-01-27 JP JP2007552583A patent/JP2008528532A/ja not_active Withdrawn
- 2006-01-27 EP EP06706448A patent/EP1841417A2/en not_active Withdrawn
-
2007
- 2007-06-14 IL IL183973A patent/IL183973A0/en unknown
- 2007-08-27 NO NO20074361A patent/NO20074361L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070096058A (ko) | 2007-10-01 |
AU2006208630A1 (en) | 2006-08-03 |
BRPI0607043A2 (pt) | 2009-08-04 |
CA2595330A1 (en) | 2006-08-03 |
NO20074361L (no) | 2007-10-26 |
MX2007009070A (es) | 2007-09-12 |
EA015566B1 (ru) | 2011-10-31 |
WO2006079547A3 (en) | 2006-09-21 |
AU2006208630B2 (en) | 2011-09-29 |
IL183973A0 (en) | 2008-12-29 |
JP2008528532A (ja) | 2008-07-31 |
EP1841417A2 (en) | 2007-10-10 |
EA200701594A1 (ru) | 2008-02-28 |
WO2006079547A2 (en) | 2006-08-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR057643A1 (es) | Lacosamida para terapia adjunta | |
NL300936I2 (nl) | Semaglutide | |
CY1122522T1 (el) | Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος | |
CL2007002327A1 (es) | Compuestos derivados de fenil-imidazol sustituido; composicion farmaceutica; y uso en el tratamiento del vhc. | |
CL2008001234A1 (es) | Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer. | |
UA94221C2 (en) | Lipocalin protein | |
PA8637301A1 (es) | Derivados de amino-5, 5-difenilimidazolona para la inhibicion de la b-secretasa | |
CL2007002384A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis. | |
CL2009001099A1 (es) | Uso de una muteina de interleuquina-2 humana para el tratamiento y/o prevencion de una enfermedad autoinmune. | |
DK1863899T3 (da) | Hudbehandlingspræparater | |
ATE481984T1 (de) | Vakzine-peptid-kombinationen gegen katzenallergie | |
NI201000093A (es) | Toalla para llevar puesta | |
CL2008000910A1 (es) | Proteina de fusion que comprende una proteina que corta el peptido beta amiloide; composicion farmaceutica que la comprende, y su uso para prevenir y/o tratar enfermedades relacionadas con el peptido beta amiloide. | |
AR058173A1 (es) | Uso de sdf-1 para el tratamiento y/o prevencion de enfermedades neurologicas | |
CL2007000595A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras. | |
FR2864552B1 (fr) | Traitement de surface par hydroxysulfate | |
CL2007002380A1 (es) | Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica. | |
TW200637538A (en) | Lacosamide for add-on-therapy | |
UY29417A1 (es) | Agentes endoparasiticidas | |
WO2008028963A3 (en) | Calreticulin for its use as a medication for the treatment of cancer in a mammal | |
UY28344A1 (es) | Nuevos compuestos | |
ATE511512T1 (de) | Olanzapinpamoat-dihydrat | |
CL2008000865A1 (es) | Compuestos derivados de benzimidazol-2-ona; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de un trastorno psicotico o un deterioro cognitivo. | |
DE10394003D2 (de) | Textilbehandlungsmittel | |
DE60322942D1 (de) | Textilbehandlung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |